Type 1 fimbrial adhesin (FimH) (FimH)

Fimbriae-mediated adhesion is a key virulence mechanism of many pathogenic bacteria, especially *Escherichia coli*. The process relies on the FimH adhesin protein located at the tip of type 1 fimbriae (pili). FimH specifically binds to mannose residues on host cell glycoproteins through a catch-bond mechanism that is strengthened by fluid shear, enabling bacteria to colonize tissues subject to flow, such as urinary tract epithelia. This interaction supports the formation of stable bacterial attachments that resist clearance, initiates biofilm formation, and can facilitate internalization into host immune cells like macrophages, aiding in chronic infection and immune evasion. FimH-mediated adhesion is a well-verified therapeutic target; competitive inhibitors such as D-mannose and synthetic FimH antagonists are under development for the prevention and treatment of urinary tract and device-associated infections. The system’s complexity includes dynamic allosteric regulation and resistance to mechanical stress, making FimH a prototype for mechanical force-dependent ligand-receptor interactions in infection biology.

Other names

Type 1 fimbrial adhesinFimHMannose-specific fimbrial adhesinE. coli type 1 pili tip protein

Competitive inhibition of FimH binding to host cell mannose receptors; Allosteric inhibition of FimH adhesin conformational changes; Blockade of catch-bond formation under flow conditions